This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignees: Covx Technologies Ireland Limited, Pfizer Corporation. Active years: 2014.
Company Filing History:
1 out of 5 
1 out of 4,486 
Years Active: 2014
Title: Bernard Norman Violand: Innovator in Anti-Diabetic Solutions
Introduction
Bernard Norman Violand is a notable inventor based in Wildwood, MO (US). He has made significant contributions to the field of diabetes treatment through his innovative research and development.
Latest Patents
Violand holds a patent for "FGF21 conjugates and anti-diabetic uses thereof." This invention provides a FGF21 molecule covalently attached to the combining site of an antibody via a linker. The linker is covalently attached to the side chain of a linking residue within FGF21. Various uses of the compounds are provided, including methods to prevent or treat diabetes or diabetes-related conditions. He has 1 patent to his name.
Career Highlights
Throughout his career, Violand has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Covx Technologies Ireland Limited and Pfizer Corporation, where he contributed to advancements in medical research.
Collaborations
Some of his notable coworkers include Tapan Kanti Das and Tamara Shafer Hodge, who have collaborated with him on various projects.
Conclusion
Bernard Norman Violand's work in developing anti-diabetic solutions showcases his commitment to improving healthcare through innovation. His contributions continue to impact the field positively.